×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateur : Pr Jean-Emmanuel Kurtz (ICANS Strasbourg)

18:00
Introduction du partenariat avec le Cancéropôle
Rachel Groubet (Cancéropôle Est)
 
18:05
Les ADCs Anti-HER2, mécanismes d’action & de résistance et solutions d’après
Pr Sylvain Ladoire (CGFL Dijon)
 
18:20
Les inhibiteurs de tyrosine kinase Anti-HER2, classe thérapeutique à part entière, du mécanisme d’action à l’effet thérapeutique
Pr Thierry Petit (ICANS Strasbourg)
 
 
18:35
Cas clinique/Synthèse des stratégies thérapeutiques actuelles et perspectives
Dr Isabelle Desmoulins & Pr Sylvain Ladoire (CGFL Dijon)
 
18:50
Débat/Discussion - Réponses aux questions
Ensemble des intervenants
 
  
Shooting date : 2022-10-13
Last update : 2022-10-14

Suggestions

Thursday, October 14th 2021 from 06pm to 07pm (GMT+2)
Honolulu : Thursday, October 14th 2021 from 07am to 08am (GMT+2)
San Francisco : Thursday, October 14th 2021 from 10am to 11am (GMT+2)
New York : Thursday, October 14th 2021 from 01pm to 02pm (GMT+2)
Buenos Aires : Thursday, October 14th 2021 from 02pm to 03pm (GMT+2)
Reykjavik : Thursday, October 14th 2021 from 05pm to 06pm (GMT+2)
London / Dublin : Thursday, October 14th 2021 from 06pm to 07pm (GMT+2)
Paris / Berlin : Thursday, October 14th 2021 from 07pm to 08pm (GMT+2)
Istanbul : Thursday, October 14th 2021 from 08pm to 09pm (GMT+2)
Moscou / Dubaï : Thursday, October 14th 2021 from 09pm to 10pm (GMT+2)
Bangkok : Friday, October 15th 2021 from 12am to 01am (GMT+2)
Shanghai : Friday, October 15th 2021 from 01am to 02am (GMT+2)
Tokyo : Friday, October 15th 2021 from 02am to 03am (GMT+2)
Sydney : Friday, October 15th 2021 from 04am to 05am (GMT+2)
Wellington : Friday, October 15th 2021 from 06am to 07am (GMT+2)

Le cancer du sein métastatique HER2 +, standards actuels et orientations futures

Octobre Rose 2021

Share
Tuesday, December 21st 2021 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, December 21st 2021 from 07am to 08:30am (GMT+1)
San Francisco : Tuesday, December 21st 2021 from 09am to 10:30am (GMT+1)
New York : Tuesday, December 21st 2021 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Tuesday, December 21st 2021 from 02pm to 03:30pm (GMT+1)
London / Dublin : Tuesday, December 21st 2021 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Tuesday, December 21st 2021 from 06pm to 07:30pm (GMT+1)
Istanbul : Tuesday, December 21st 2021 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Tuesday, December 21st 2021 from 09pm to 10:30pm (GMT+1)
Bangkok : Wednesday, December 22nd 2021 from 12am to 01:30am (GMT+1)
Shanghai : Wednesday, December 22nd 2021 from 01am to 02:30am (GMT+1)
Tokyo : Wednesday, December 22nd 2021 from 02am to 03:30am (GMT+1)
Sydney : Wednesday, December 22nd 2021 from 03am to 04:30am (GMT+1)
Wellington : Wednesday, December 22nd 2021 from 05am to 06:30am (GMT+1)

Indication de chimiothérapie néoadjuvante dans la prise en charge des patientes atteintes d’un c...

Share
Wednesday, April 20th 2022 from 06pm to 07:30pm (GMT+2)
Honolulu : Wednesday, April 20th 2022 from 07am to 08:30am (GMT+2)
San Francisco : Wednesday, April 20th 2022 from 10am to 11:30am (GMT+2)
New York : Wednesday, April 20th 2022 from 01pm to 02:30pm (GMT+2)
Buenos Aires : Wednesday, April 20th 2022 from 02pm to 03:30pm (GMT+2)
Reykjavik : Wednesday, April 20th 2022 from 05pm to 06:30pm (GMT+2)
London / Dublin : Wednesday, April 20th 2022 from 06pm to 07:30pm (GMT+2)
Paris / Berlin : Wednesday, April 20th 2022 from 07pm to 08:30pm (GMT+2)
Istanbul : Wednesday, April 20th 2022 from 08pm to 09:30pm (GMT+2)
Moscou / Dubaï : Wednesday, April 20th 2022 from 09pm to 10:30pm (GMT+2)
Bangkok : Thursday, April 21st 2022 from 12am to 01:30am (GMT+2)
Shanghai : Thursday, April 21st 2022 from 01am to 02:30am (GMT+2)
Tokyo : Thursday, April 21st 2022 from 02am to 03:30am (GMT+2)
Sydney : Thursday, April 21st 2022 from 04am to 05:30am (GMT+2)
Wellington : Thursday, April 21st 2022 from 06am to 07:30am (GMT+2)

Cancer du sein

Cycle de formation en oncologie gynécologique et sénologique de l’Institut Curie

Share
Friday, February 9th 2024 from 05:30pm to 07pm (GMT+1)
Honolulu : Friday, February 9th 2024 from 06:30am to 08am (GMT+1)
San Francisco : Friday, February 9th 2024 from 08:30am to 10am (GMT+1)
New York : Friday, February 9th 2024 from 11:30am to 01pm (GMT+1)
Buenos Aires : Friday, February 9th 2024 from 01:30pm to 03pm (GMT+1)
London / Dublin : Friday, February 9th 2024 from 04:30pm to 06pm (GMT+1)
Paris / Berlin : Friday, February 9th 2024 from 05:30pm to 07pm (GMT+1)
Istanbul : Friday, February 9th 2024 from 06:30pm to 08pm (GMT+1)
Moscou / Dubaï : Friday, February 9th 2024 from 08:30pm to 10pm (GMT+1)
Bangkok : Friday, February 9th 2024 from 11:30pm to 01am (GMT+1)
Shanghai : Saturday, February 10th 2024 from 12:30am to 02am (GMT+1)
Tokyo : Saturday, February 10th 2024 from 01:30am to 03am (GMT+1)
Sydney : Saturday, February 10th 2024 from 02:30am to 04am (GMT+1)
Wellington : Saturday, February 10th 2024 from 04:30am to 06am (GMT+1)

Le réseau FEM-NET, position du problème pour les cancers du sein triples négatifs métastatiques

Les webinars du réseau FEM-NET

Share
Scroll Up